对于帕金森病的物理疗法康复方法的有效性:达勒斯的案例研究
Aida Zotaj1, Rajmonda Milloshi2, Selda Sokoli1
1Department of Medical Technical Sciences, Aleksandër Moisiu University of Durrës, Durres, Albania.
概括
物理治疗有效地治疗帕金森病 (PD) 的症状,如布拉迪基尼西亚和震,改善功能和减缓进展. 量身定制的康复计划至关重要,特别是对于老年人来说,以最大限度地提高效益和长期结果.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 老年病的医生 老年病的医生
背景情况:
- 帕金森病 (PD) 的风险正在上升,需要先进的康复策略.
- 物理治疗在治疗PD症状和改善患者生活质量方面发挥着关键作用.
研究的目的:
- 评估物理治疗对帕金森病患者的直接影响.
- 评估物理治疗在缓解心肺衰退,增强姿势,平衡以及减少肌肉运动和震方面的作用.
主要方法:
- 2011-2022年407名帕金森病患者 (30-100岁) 的临床数据分析.
- 系统的文献综述和物理治疗结果与欧盟标准的统计比较.
主要成果:
- 物理疗法在帕金森病管理中显示出短期和长期的疗效.
- 观察到运动症状,姿势和平衡的改善,特别是在30-80岁的患者中.
- 随着年龄的增长,物理治疗的有效性可能会下降;先进的方法显示出有前途.
结论:
- 对老年帕金森病患者来说,增强和量身定制的康复计划是必不可少的.
- 建议进行标准化,培训和长期监测,以获得最佳结果.
- 未来的研究应该专注于长期益处和创新的治疗方法.
关键词:
神经退行性疾病神经退行性疾病帕金森主义是帕金森主义.物理治疗康复 物理治疗康复人们的生活质量.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,更多相关视频
05:28Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies
Published on: October 11, 2024
526
00:07Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
9.7K
相关概念视频
01:24Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
01:15Parkinson's Disease: Overview
500
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
500